Targeted Therapies in Autoimmune and Inflammatory Skin Disorders
Rüdiger Eming(Philipps University of Marburg), Ingo H. Tarner(Justus-Liebig-Universität Gießen)
Cited by 0
Related Papers
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|384
Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
|Science Translational Medicine|2013|246
Pemphigus: Current and Future Therapeutic Strategies
|Frontiers in Immunology|2019|245
Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.
|Journal of Clinical Investigation|1998|235
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
|Arthritis Research & Therapy|2011|212